Altered angiogenesis as a common mechanism underlying preterm birth, small for gestational age, and stillbirth in women living with HIV
Open Access
- 1 December 2017
- journal article
- research article
- Published by Elsevier in American Journal of Obstetrics and Gynecology
- Vol. 217 (6) , 684.e1-684.e17
Abstract
No abstract availableKeywords
This publication has 56 references indexed in Scilit:
- Why is placentation abnormal in preeclampsia?American Journal of Obstetrics and Gynecology, 2015
- Inflammatory and Angiogenic Factors at Mid-Pregnancy Are Associated with Spontaneous Preterm Birth in a Cohort of Tanzanian WomenPLOS ONE, 2015
- Risk Factors for Preterm Birth Among HIV-Infected Pregnant Ugandan Women Randomized to Lopinavir/Ritonavir- or Efavirenz-Based Antiretroviral TherapyJAIDS Journal of Acquired Immune Deficiency Syndromes, 2014
- HIV Protease Inhibitor Use During Pregnancy Is Associated With Decreased Progesterone Levels, Suggesting a Potential Mechanism Contributing to Fetal Growth RestrictionThe Journal of Infectious Diseases, 2014
- Highly Active Antiretroviral Therapy and Adverse Birth Outcomes Among HIV-Infected Women in BotswanaThe Journal of Infectious Diseases, 2012
- An imbalance between angiogenic and anti-angiogenic factors precedes fetal death in a subset of patients: results of a longitudinal studyThe Journal of Maternal-Fetal & Neonatal Medicine, 2010
- Plasma soluble endoglin concentration in pre‐eclampsia is associated with an increased impedance to flow in the maternal and fetal circulationsUltrasound in Obstetrics & Gynecology, 2010
- A subset of patients destined to develop spontaneous preterm labor has an abnormal angiogenic/anti-angiogenic profile in maternal plasma: Evidence in support of pathophysiologic heterogeneity of preterm labor derived from a longitudinal studyThe Journal of Maternal-Fetal & Neonatal Medicine, 2009
- Aspects of Human Fetoplacental Vasculogenesis and Angiogenesis. I. Molecular RegulationPlacenta, 2004
- Human Placental Vascular Development: Vasculogenic and Angiogenic (Branching and Nonbranching) Transformation Is Regulated by Vascular Endothelial Growth Factor-A, Angiopoietin-1, and Angiopoietin-2The Journal of Clinical Endocrinology & Metabolism, 2002